About Validant
Validant is a company based in San Francisco (United States) founded in 2005 was acquired by GHO Capital Partners in December 2018. Validant has raised $2.28 million across 3 funding rounds from investors including Permira and GHO Capital. Validant has completed 6 acquisitions, including Clinical Outcomes Solutions, DataRevive and Eliquent Japan. Validant offers products and services including Strategic Consulting, Execution Services, and Ongoing Support. Validant operates in a competitive market with competitors including ProPharma Group, PharmaLex, Technical Safety Services, Celegence and Trasis, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kinsale Holdings, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.28 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Permira
& 1 more
-
Employee Count
Not available
-
Investments & Acquisitions
Clinical Outcomes Solutions
& 5 more
-
Acquired by
GHO Capital Partners
(Dec 20, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Validant
Validant offers a comprehensive portfolio of products and services, including Strategic Consulting, Execution Services, and Ongoing Support.
Develops strategies for regulatory compliance and business needs
Deploys teams for hands-on strategy execution
Offers training and monitoring for sustained compliance
People of Validant
Unlock access to complete
Funding Insights of Validant
Validant has successfully raised a total of $2.28M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Validant
Validant has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Permira and GHO Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in technology, consumer, healthcare, and service sectors.
|
Locked | Locked | Locked | |
|
Specialist healthcare investment advisory services are provided by GHO Capital.
|
Locked | Locked | Locked |
Investor details for Validant
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Validant
Validant has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Clinical Outcomes Solutions, DataRevive and Eliquent Japan.
Investment portfolio details for Validant
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
CMC, nonclinical, and clinical regulatory consulting for biologics is provided.
|
Locked | Locked | 2016 | Locked | |
|
Regulatory support and consulting services are provided for clinical outcomes.
|
Locked | Locked | 2013 | Locked | |
|
Regulatory consulting services are provided to medical device companies.
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for Validant
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Validant
Detailed financials for Validant
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Validant Comparisons
Peer comparison for Validant
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Validant
Validant operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ProPharma Group, PharmaLex, Technical Safety Services, Celegence and Trasis, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device
|
|
| Locked | Locked | Locked |
CRO specializing in regulatory affairs and pharmacovigilance
|
|
| Locked | Locked | Locked |
Healthcare instrumentation, medical gas systems, and related devices are manufactured.
|
|
| Locked | Locked | Locked |
Regulatory consulting and solutions for pharmaceuticals and medical devices compliance.
|
|
| Locked | Locked | Locked |
Provides radiopharmaceutical equipment, synthesis solutions, and custom services for labs.
|
Detailed competitors of Validant
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Validant
Complete news archive for Validant
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Validant
Validant was founded in 2005 and raised its 1st funding round 6 years after it was founded.
Validant is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Validant is a funded company, having raised a total of $2.28M across 3 funding rounds to date.
Validant was founded in 2005 and is headquartered in San Francisco, United States. Services in regulatory compliance and quality consulting are offered across pharmaceuticals, biologics, medical devices, diagnostics, and gene and cell therapies. Operations cover preclinical, clinical, manufacturing, and distribution phases of GxP product lifecycles. Strategic planning, implementation, and ongoing maintenance support are provided to navigate approvals and ensure product integrity.
Validant's top competitors include ProPharma Group, PharmaLex and Pharma-Bio Serv.
Validant offers Strategic Consulting, Execution Services, and Ongoing Support.
Validant has made 6 acquisitions, including Clinical Outcomes Solutions, DataRevive, and Eliquent Japan.
Validant has 2 investors. Key investors include Permira, and GHO Capital.